Nothing Special   »   [go: up one dir, main page]

PL1756086T3 - Pirydyn-4-ylo-etynylo-imidazole i pirazole jako antagoniści receptora mGlu5 - Google Patents

Pirydyn-4-ylo-etynylo-imidazole i pirazole jako antagoniści receptora mGlu5

Info

Publication number
PL1756086T3
PL1756086T3 PL05744719T PL05744719T PL1756086T3 PL 1756086 T3 PL1756086 T3 PL 1756086T3 PL 05744719 T PL05744719 T PL 05744719T PL 05744719 T PL05744719 T PL 05744719T PL 1756086 T3 PL1756086 T3 PL 1756086T3
Authority
PL
Poland
Prior art keywords
pyrazoles
imidazoles
ethynyl
pyridin
receptor antagonists
Prior art date
Application number
PL05744719T
Other languages
English (en)
Inventor
Bernd Buettelmann
Simona Maria Ceccarelli
Georg Jaeschke
Sabine Kolczewski
Richard Hugh Philip Porter
Eric Vieira
Paul Spurr
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34968402&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1756086(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/EP2004/005881 external-priority patent/WO2004108701A1/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PL1756086T3 publication Critical patent/PL1756086T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL05744719T 2004-06-01 2005-05-23 Pirydyn-4-ylo-etynylo-imidazole i pirazole jako antagoniści receptora mGlu5 PL1756086T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/EP2004/005881 WO2004108701A1 (en) 2003-06-05 2004-06-01 Imidazole derivatives as glutmate receptor antagonists
EP04021216 2004-09-07
EP05744719A EP1756086B1 (en) 2004-06-01 2005-05-23 Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists
PCT/EP2005/005559 WO2005118568A1 (en) 2004-06-01 2005-05-23 Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists

Publications (1)

Publication Number Publication Date
PL1756086T3 true PL1756086T3 (pl) 2008-11-28

Family

ID=34968402

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05744719T PL1756086T3 (pl) 2004-06-01 2005-05-23 Pirydyn-4-ylo-etynylo-imidazole i pirazole jako antagoniści receptora mGlu5

Country Status (10)

Country Link
EP (1) EP1756086B1 (pl)
CN (1) CN1960984B (pl)
AT (1) ATE397601T1 (pl)
AU (1) AU2005250101B2 (pl)
CA (1) CA2568725C (pl)
DE (1) DE602005007350D1 (pl)
MX (1) MXPA06013603A (pl)
PL (1) PL1756086T3 (pl)
RS (1) RS50603B (pl)
WO (1) WO2005118568A1 (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006011574A1 (de) * 2006-03-10 2007-10-31 Grünenthal GmbH Substituierte Imidazo[2,1-b]thiazol-Verbindungen und ihre Verwendung zur Herstellung von Arzneimitteln
AU2007267183B2 (en) 2006-05-31 2011-10-20 F. Hoffmann-La Roche Ag Aryl-4-ethynyl-isoxazole derivatives
JP5405311B2 (ja) * 2006-12-21 2014-02-05 エフ.ホフマン−ラ ロシュ アーゲー mGluR5受容体アンタゴニストの多形
CN101965344B (zh) 2007-06-22 2013-03-06 弗·哈夫曼-拉罗切有限公司 异*唑-咪唑衍生物
WO2009024491A1 (en) * 2007-08-20 2009-02-26 F. Hoffmann-La Roche Ag Use of mglur5 antagonists for the treatment of gerd
US7618973B2 (en) 2007-12-04 2009-11-17 Hoffmann-La Roche Inc. Isoxazolo-pyrazine derivatives
US7902201B2 (en) 2007-12-04 2011-03-08 Hoffmann-La Roche Inc. Isoxazolo-pyrazine derivatives
US7943619B2 (en) 2007-12-04 2011-05-17 Hoffmann-La Roche Inc. Isoxazolo-pyridazine derivatives
TW201033201A (en) 2009-02-19 2010-09-16 Hoffmann La Roche Isoxazole-isoxazole and isoxazole-isothiazole derivatives
US8389550B2 (en) 2009-02-25 2013-03-05 Hoffmann-La Roche Inc. Isoxazoles / O-pyridines with ethyl and ethenyl linker
US8222246B2 (en) 2009-04-02 2012-07-17 Hoffmann-La Roche Inc. Substituted isoxazoles
US8227461B2 (en) 2009-04-30 2012-07-24 Hoffmann-La Roche Inc. Isoxazoles
CA2760166C (en) 2009-05-05 2017-07-18 F. Hoffmann-La Roche Ag Isoxazole-pyridine derivatives
BRPI1014454A2 (pt) 2009-05-05 2016-04-05 Hoffmann La Roche derivados de isoxazol-pirazol
WO2010127968A1 (en) 2009-05-05 2010-11-11 F. Hoffmann-La Roche Ag Isoxazole-pyridazine derivatives
CN102414208B (zh) 2009-05-05 2014-11-05 霍夫曼-拉罗奇有限公司 作为用于认知性障碍的治疗中的gaba a受体逆激动剂的异*唑-噻唑衍生物
AU2010244555A1 (en) 2009-05-07 2011-11-03 F. Hoffmann-La Roche Ag Isoxazole-pyridine derivatives as GABA modulators
US8334287B2 (en) * 2009-07-17 2012-12-18 Hoffmann-La Roche Inc. Imidazoles
US20120040008A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120039999A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20140228398A1 (en) 2011-03-18 2014-08-14 Novartis Ag COMBINATIONS OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATORS AND mGluR5 ANTAGONISTS FOR USE IN DOPAMINE INDUCED DYSKINESIA IN PARKINSON'S DISEASE
US8785435B2 (en) 2011-10-20 2014-07-22 Hoffmann-La Roche Inc. Solid forms
WO2013163402A1 (en) * 2012-04-26 2013-10-31 Massachusetts Institute Of Technology Methods for treatment of 16p11.2 microdeletion syndrome
UA113223C2 (xx) * 2012-08-13 2016-12-26 Арилетинілпіримідини

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2383524C (en) * 1999-08-31 2010-09-28 Merck & Co., Inc. Thiazolyl alkynyl compounds and methods of use thereof
KR100515549B1 (ko) * 2000-12-04 2005-09-20 에프. 호프만-라 로슈 아게 글루타메이트 수용체 길항제로서의 페닐에테닐 또는페닐에티닐 유도체
TWI292318B (en) * 2003-03-10 2008-01-11 Hoffmann La Roche Imidazol-4-yl-ethynyl-pyridine derivatives
US7091222B2 (en) * 2003-07-03 2006-08-15 Hoffmann-La Roche Inc. Imidazole derivatives
US7452909B2 (en) * 2003-09-04 2008-11-18 Hoffman-La Roche Inc. Imidazole derivatives

Also Published As

Publication number Publication date
AU2005250101A1 (en) 2005-12-15
AU2005250101B2 (en) 2011-08-25
EP1756086A1 (en) 2007-02-28
CA2568725C (en) 2012-11-27
RS50603B (sr) 2010-05-07
CN1960984B (zh) 2010-05-12
ATE397601T1 (de) 2008-06-15
CA2568725A1 (en) 2005-12-15
WO2005118568A1 (en) 2005-12-15
MXPA06013603A (es) 2007-02-08
DE602005007350D1 (de) 2008-07-17
EP1756086B1 (en) 2008-06-04
CN1960984A (zh) 2007-05-09

Similar Documents

Publication Publication Date Title
PL1756086T3 (pl) Pirydyn-4-ylo-etynylo-imidazole i pirazole jako antagoniści receptora mGlu5
MY143565A (en) Novel fluorocglycoside derivatives of pyrazoles: medicaments containing these compounds, and the use thereof
IL176547A0 (en) 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
SE0202539D0 (sv) Compounds
MY139303A (en) Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
MX2009006860A (es) Derivados de 2-aza-biciclo[3.1.0]hexano como antagonistas del receptor orexina.
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MX2009005174A (es) Derivados de 5-sulfanilmetil-[1,2,4]triazol[1,5-a]pirimidin-7-ol como antagonistas de cxcr2.
MY145613A (en) Novel compounds
TW200639156A (en) New compounds
MX2010008713A (es) Derivados de 5,6-bisaril-2-piridina-carboxamida, su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de la urotensina ii.
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
MX2009006010A (es) Derivados de amina y su uso en enfermedades mediadas por el adrenoreceptor beta 2.
IL183636A0 (en) Quinoline derivative, use and production thereof, and drug containing the same
MY143353A (en) Diazole derivatives
EP1398029A8 (en) NR3B1 nuclear receptor binding 3-substituted pyrazole derivatives
NZ552137A (en) New 4-benzylidene-piperidin derivatives
IL165558A0 (en) N-benzoylureidocinnamate derivatives method for production and use thereof
WO2005075450A3 (en) Spiro-benzodioxoles and their use as cb1 antagonists
SE0401763D0 (sv) Compounds
MXPA04004981A (es) Derivados de piperazina para uso como antagonistas del receptor ccr-3 en tratamiento de asma.
IL166057A0 (en) Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments
TW200630352A (en) Chemical compounds
TW200738611A (en) 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments